Decreased beta2 adrenergic mediated venodilatation in Native Americans

International Angiology

Volumn 17, Issue 4, 1998, Pages 276-281

  Vajo, Z ^a   Cruz, E ^a   Szekacs, B ^b   Dachman, W ^a  

^a MARICOPA MEDICAL CENTER   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Caucasoid race; Hypertension therapy; Indians, North American

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; PHENYLEPHRINE; VASOACTIVE AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIAGNOSTIC AGENT;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADULT; AMERICAN INDIAN; ANTIHYPERTENSIVE THERAPY; ARTICLE; CAUCASIAN; CLINICAL TRIAL; ESSENTIAL HYPERTENSION; ETHNIC GROUP; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; RACE DIFFERENCE; STATISTICAL ANALYSIS; VEIN DILATATION; COMPARATIVE STUDY; DRUG EFFECT; ETHNOLOGY; HAND; PHYSIOLOGY; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION; VEIN;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAND; HUMANS; HYPERTENSION; INDIANS, NORTH AMERICAN; ISOPROTERENOL; MALE; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, BETA-2; VASOCONSTRICTION; VASODILATION; VEINS;

EID: 0032216806     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990;132(6):1141-55.
2. Martinez-Maldonado M. Hypertension in Hispanics, Asians and Pacific-Islanders, and Native-Americans. Circulation 1991;83(4):1467-9.
3. Broussard BA, Valway SE, Kaufman S, Beaver S, Gohdes D. Clinical hypertension and its interaction with diabetes among American Indians and Alaska Natives. Estimated rates from ambulatory care data. Diabetes Care 1993;16(1):292-6.
4. Aronoff SL, Bennett PH, Corden P, Rushfort N, Miller M. Unexplained hyperinsulinemia in normal and "prediabetic" Pima Indians compared with normal Caucasians. An example of racial differences in insulin secretion. Diabetes 1977;26(9);827-40.
5. Nagulesparan M, Savage PJ, Knowler WC, Johnson GC, Bennett PH. Increased in vivo insulin resistance in nondiabetic Pima Indians compared with Caucasians. Diabetes 1982;31(11):952-6.
6. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990;39(11):1430-5.
7. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317(6): 350-7.
8. Reavan GM. Role of insulin resistance in human disease. Banting lecture 1988. Diabetes 1988;37:1595-607.
9. Mbanya JC, Thomas TH, Wilkinson R, Alberti KG, Taylor A. Hypertension and hyperinsulinemia: a relation in diabetes but not in essential hypertension. Lancet 1988;1(8588):733-4.
10. Sugarman JR. Prevalence of diagnosed hypertension among diabetic Navajo Indians. Arch Intern Med 1990;150(2):359-62.
11. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Int Med 1993;153:154-83.
12. Eichler HG, Blaschke TF, Huffman BB. Decreased responsiveness of superficial hand veins to phenylephrine in black normotensive males. J Cardiovasc Pharmacol 1990;16(2):177-81.
13. Vincent J, Elliott HL, Meredith PA, Reid JL. Racial differences in drug responses - a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans. Br J Clin Pharmacol 1986;21(4):401-8.
14. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS et al. Single drug therapy for hypertension in men. N Engl J Med 1993;328:914-21.
15. Lund-Johansen P. Hemodynamics in hypertension at rest and during exercise. J Cardiovasc Pharmacol 1987;10 (Suppl. 11):S1-5.
16. Greenberg S, Bohr DE Venous smooth muscle in hypertension. Enhanced contractility of portal veins from spontaneously hypertensive rats. Circ Res 1975; 36(6 Suppl 1):208-15.
17. Gudmundsson O, Wikstrand J, Andersson O, Berglund G. Haemodynamics in young normotensive men with familial predisposition to hypertension. Predisposition to hypertension. Studies on normal and increased salt intake. Scand J Clin Lab Invest 1985;176(Suppl):38-46.
18. Luthra A, Borkowski KR, Carruthers SG. Genetic aspects of variability in superficial vein responsiveness to norepinephrine. Clin Pharmacol Ther 1991; 49(4):355-61.
19. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol 1981;11: 237-43.
20. Eichler HG, Ford GA, Blaschke TF, Swislocki A, Hoffman BB. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy. J Clin Invest 1989;83(1):108-12.